4.3 Review

Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Cho Mar Myint Wai et al.

Summary: Primary EBV-positive nodal T/NK-cell lymphoma is a distinct entity characterized by low genomic instability, upregulation of immune pathways, and downregulation of EBV miRNA expression.

HAEMATOLOGICA (2022)

Article Hematology

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo et al.

Summary: Since 1994, the classification of lymphoid neoplasms has been continuously updated through international efforts, with recent progress driven by genomic studies. This proposal presents the International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors, which has refined diagnostic criteria and incorporated new insights from genomics.
Article Pathology

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Alina Nicolae et al.

Summary: This study examined the clinicopathological and molecular characteristics of nodal peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with cytotoxic phenotype in Western patients. The findings revealed that this rare disease in the Western population is associated with aggressive behavior and impaired immunity.

MODERN PATHOLOGY (2022)

Article Oncology

Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice

Catalina Amador et al.

Summary: This study aims to classify PTCL subtypes using transcriptomic signatures to improve diagnostic accuracy and precision in clinical practice.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Hematology

Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence de Leval et al.

Summary: With the introduction of large-scale molecular profiling methods and high-throughput sequencing technologies, the genomic features of most lymphoid neoplasms have been characterized at an unprecedented scale. However, the current diagnosis of lymphoid tumors is largely based on morphological assessment and immunophenotyping, with only few entities being defined by genomic criteria. This paper discusses how established and newly developed molecular testing technologies complement clinical diagnoses and contribute to refining diagnosis, risk stratification, and therapy prediction for lymphoid neoplasms. Future methods such as whole-genome sequencing, circulating tumor DNA analyses, single-cell analyses, and epigenetic profiling are likely to become important tools for implementing precision medicine approaches in clinical decision making for lymphoid malignancies.
Article Hematology

Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target

Hugo Larose et al.

Summary: This study identified a variant in the extracellular domain of NOTCH1 in ALCL patients, demonstrating that the Notch pathway is a viable second-line druggable target for ALK(+) ALCL.

HAEMATOLOGICA (2021)

Article Pathology

Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical Hyperplasia A Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin

Ibrahim Abukhiran et al.

Summary: The study found that AITL more frequently coexpressed more than 2 TFH markers, while PTCL-NOS and PTCL-TFH did not show this phenomenon. The expression of TFH markers also varied in different backgrounds. Caution should be exercised when diagnosing AITL.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Pathology

JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology

Megan J. Fitzpatrick et al.

Summary: This study identified JAK2 rearrangements in a subset of CD30(+) ALK(-) systemic PTCL with anaplastic morphology, some of which showed CHL-like morphologic features. The presence of JAK2 rearrangements expands current classification and may offer a therapeutic target through JAK2 inhibition.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Hematology

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi et al.

Summary: The combination of histone deacetylase inhibitors and DNA methyltransferase inhibitors showed high activity and safety in patients with PTCL, with particularly good outcomes in tTFH phenotype patients. This combination could potentially serve as a platform for novel regimens in the treatment of PTCL.
Article Hematology

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers

Marta Rodriguez et al.

Summary: This study analyzed cases of Peripheral T-cell lymphoma (PTCL) to identify specific gene sets associated with different histological types, supporting the division of PTCL into 3 categories and identifying B-cell gene expression as an independent prognostic factor for AITL. The study also highlighted the importance of mutational profiles, with differences in RHOA mutations among the PTCL classes.

BLOOD ADVANCES (2021)

Review Pathology

How I Diagnose Angioimmunoblastic T-Cell Lymphoma

Yi Xie et al.

Summary: AITL, a subtype of peripheral T-cell lymphoma derived from T-follicular helper cells, poses diagnostic challenges due to its wide clinical and histopathologic spectrum. Diagnostic tools and molecular studies play crucial roles in aiding accurate diagnosis and differential diagnosis.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Pathology

Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay

Fanny Drieux et al.

Summary: This study developed a multiplex ligation-dependent RT-PCR-based assay to detect 33 known PTCL-associated fusion transcripts, providing an efficient tool for identifying genetic variations in PTCL. The research found that in 239 different types of PTCL, in addition to ALK fusion transcripts, there are various non-ALK fusion transcripts, with ICOS_CD28 being the most common.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Article Pathology

Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma A Potential Diagnostic Pitfall

Caoimhe Egan et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Review Hematology

Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification

Seiichi Kato et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2020)

Letter Hematology

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma

Greg Hapgood et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Article Multidisciplinary Sciences

Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress

Tim I. M. Malcolm et al.

NATURE COMMUNICATIONS (2016)

Article Pathology

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements

Rebecca L. King et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

Article Multidisciplinary Sciences

The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck

Ju-Pi Li et al.

NATURE COMMUNICATIONS (2014)